Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,934 papers from all fields of science
Search
Sign In
Create Free Account
LS 2616
Known as:
LS-2616
, LS2616
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Linomide
Broader (1)
roquinimex
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus.
H. Carlsten
,
C. Jonsson
,
M. Bokarewa
,
L. Svensson
,
A. Tarkowski
International Immunopharmacology
2004
Corpus ID: 29915366
1997
1997
Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions
X. Bai
,
F. Shi
,
Jie Zhu
,
B. Xiao
,
G. Hedlund
,
H. Link
Journal of Neuroimmunology
1997
Corpus ID: 24320842
1997
1997
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis
D. Lehmann
,
D. Karussis
,
+5 authors
O. Abramsky
Journal of Neuroimmunology
1997
Corpus ID: 25003054
1993
1993
Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease.
N. Ilbäck
,
L. Wesslén
,
K. Pauksen
,
T. Stålhandske
,
G. Friman
,
J. Fohlman
Scandinavian Journal of Infectious Diseases…
1993
Corpus ID: 46319459
The effects of the anti picornaviral drug WIN 54954 (5-(5-(2.6-dichloro-4-(4.5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-me thyl…
Expand
Highly Cited
1993
Highly Cited
1993
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide
MD D. M. Karussis
,
PhD D. Lehmann
,
+8 authors
S. Slavin
Annals of Neurology
1993
Corpus ID: 25405874
Linomide (LS‐2616, quinoline‐3‐carboxamide) is a synthetic immunomodulator that stimulates natural killer cell activity and…
Expand
1991
1991
Evidence that LS-2616 (linomide) causes acute rejection of rat allografts protected by cyclosporine but not of long-term surviving allografts.
A. Wanders
,
P. Vogt
,
A. Karlsson-Parra
,
K. Wonigkeit
,
B. Gerdin
,
G. Tufveson
Transplantation
1991
Corpus ID: 8240536
The immunomodulator LS-2616 (Linomide) induces rejection of cyclosporine-protected rat cardiac allografts. The aim of this study…
Expand
1989
1989
Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice
J. Björk
,
S. Kleinau
Agents and Actions
1989
Corpus ID: 38030140
The quinoline-3-carboxamide, Linomide, has been shown to possess potent immunomodulatory activity. We have evaluated the effect…
Expand
1989
1989
ABOLITION OF THE EFFECT OF CYCLOSPORINE ON RAT CARDIAC ALLOGRAFT REJECTION BY THE NEW IMMUNOMODULATOR LS‐2616 (LINOMIDE)
A. Wanders
,
E. Larsson
,
B. Gerdin
,
G. Tufveson
Transplantation
1989
Corpus ID: 8575524
The effect of the quinoline-3-carboxamide LS-2616 (Linomide), given alone or together with cyclosporine, was studied in the first…
Expand
1989
1989
Rat cardiac allografts protected with cyclosporin A are rejected in the presence of LS-2616 (Linomide).
B. Gerdin
,
A. Wanders
,
G. Tufveson
Transplantation Proceedings
1989
Corpus ID: 27843899
Rat cardiac allografts protected with cyclosporin A are rejected in thepresence of LS-2616 (Linomide).
Highly Cited
1986
Highly Cited
1986
Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice.
A. Tarkowski
,
K. Gunnarsson
,
T. Stålhandske
Immunology
1986
Corpus ID: 36686693
Autoimmune (NZB X NZW) F1 female hybrid mice were treated with LS-2616, a recently developed substance with immunomodulating…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE